A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Medication overuse headache (MOH) is a type of headache caused by excessive use of acute headache or migraine medications (medications used to treat a headache or migraine once it begins). Treatment of MOH usually involves reducing the dose of or discontinuing acute medications. Eptinezumab is a medication used for the preventive treatment of migraine in adults. The main goals of this trial are to learn whether eptinezumab helps reduce the number of days with migraine, the number of days with headache, and acute medication use in adults who have migraine and MOH.
Epistemonikos ID: d56c9e6927a4c64f6dd863e418816ccc734cad49
First added on: May 13, 2024